Abstract
In this case report, we present the first report of erythema elevatum diutinum after treatment of juvenile idiopathic arthritis with abatacept. Although it could also be coincidental, in our case, the appearance of vasculitis was not blocked by the simultaneous administration of a stimulation inhibitor, and alerts to the fact that as effective as a abatacept may be to control of the inflammatory articular symptoms, this might not translate into control of the disease.
Similar content being viewed by others
References
Gibson LE, el-Azhary RA (2000) Erythema elevatum diutinum. Clin Dermatol 18:295–299
Crowson AN, Mihm MC Jr, Magro CM (2003) Cutaneous vasculitis: a review. J Cutan Pathol 30:161–173
Woody CM, Lane JE, Davis LS (2005) Erythema elevatum diutinum in the setting of connective tissue disease and chronic bacterial infection. J Clin Rheumatol 11:98–104
Wahl CE, Bouldin MB, Gibson LE (2005) Erythema elevatum diutinum: clinical, histopathologic, and immunohistochemical characteristics of six patients. Am J Dermatopathol 27:397–400
Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A (2003) Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 42:1452–1459
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Golmia, A., Grinblat, B., Finger, E. et al. The development of erythema elevatum diutinum in a patient with juvenile idiopathic arthritis under treatment with abatacept. Clin Rheumatol 27, 105–106 (2008). https://doi.org/10.1007/s10067-007-0743-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0743-6